An active surveillance to monitor the real world safety in Indian patients prescribed nintedanib for the treatment of Idiopathic Pulmonary Fibrosis

04/01/2017
14/10/2026
EU PAS number:
EUPAS17055
Study
Finalised
Subscribe
Download as PDF
Documents
Study protocol
Initial protocol

1199-0280_CTP.pdf

English (545.04 KB - PDF) View document
Updated protocol

1199-0280-Protocol-V5

First published: 22/02/2024
English (663.7 KB - PDF) View document
Study results
Study results

1199-0280_Synopsis.pdf

English (555.54 KB - PDF) View document
Study report
No information provided.
ENCePP Seal
No information provided.